Daysha Robinson

Patients with attention-deficit/hyperactivity disorder (ADHD) may be at higher risk of being overweight or obese. In addition, ADHD has been associated with type 2 diabetes and insulin resistance, which may contribute to the development of metabolic syndrome. Metabolic syndrome is one of the most common cardiovascular risk factors associated with high morbidity and mortality. Research...

Attention-deficit/hyperactivity disorder (ADHD) is closely associated with obsessive-compulsive disorder (OCD) in pediatric patients. ADHD comorbidity may have negative effects on treatment outcomes in patients with OCD. Attention-deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric conditions that occur concomitantly with obsessive-compulsive disorder (OCD), and the rate of concomitant occurrence is up to 60%. Although...

Patients with transthyretin amyloidosis cardiomyopathy (ATTR-CM) are at risk of cardiovascular comorbidities, including atrial fibrillation and flutter. Routine ambulatory monitoring in patients with ATTR-CM could help drive the use of anticoagulation to prevent strokes. Heart complications, such as heart failure, are common in patients with transthyretin amyloidosis cardiomyopathy (ATTR-CM). Atrial fibrillation and flutter (AF/AFL), in...

The awareness and diagnosis of wild‐type transthyretin amyloid cardiomyopathy (ATTRwt CM) is challenging, despite ATTRwt being more common than previously thought. Screening is necessary for early detection and diagnosis of ATTRwt CM, as well as for timely treatment of the disease. The clinical characteristics of wild‐type transthyretin amyloid cardiomyopathy (ATTRwt CM) can vary among affected...

Heart failure, among other cardiovascular problems, is a typical manifestation of transthyretin amyloidosis cardiomyopathy (ATTR-CM). The prevalence of ATTR-CM as a phenotype of heart failure is often underestimated. Heart failure with preserved ejection fraction (HFpEF) affects more than half of patients with heart failure. The phenotypes of heart failure can vary, and treatment modalities are...

The SABINA III study, which comprised 8351 participants from 24 countries, demonstrated that high SABA prescriptions led to poorer asthma control and higher rates of severe asthma exacerbations. Asthma is a prevalent health condition across the globe and the most common chronic condition during childhood. The emergence of inhaled corticosteroids has led to a significant...

Benralizumab is effective in patients with nasal polyposis. Severe eosinophilic asthma also exhibits improved SNOT-22 and asthma outcomes with benralizumab. The combination of chronic rhinosinusitis (CRS) and nasal polyposis (NP) is a common chronic inflammatory disease. Patients may suffer from headaches and severe sinonasal symptoms that include increased nasal congestion, nasal polyp growth, loss or...

Socioeconomic disadvantage may be a potential risk factor for poor clinical outcomes in patients with multiple sclerosis (MS). A retrospective analysis was conducted to assess this association and open the discussion for possible solutions. Patients with multiple sclerosis (MS) who are at a socioeconomic disadvantage may bear a high burden of disease and worse outcomes....

The prevalence of multiple sclerosis (MS) in minority populations is not well documented or understood. A retrospective cohort analysis evaluated the prevalence of MS with data gathered from a Florida database and provided insight into the prevalence and care of MS. Nearly one million people live with multiple sclerosis (MS) in the United States. However,...